Alan Whelan

4.3k total citations
20 papers, 287 citations indexed

About

Alan Whelan is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alan Whelan has authored 20 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 11 papers in Surgery and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alan Whelan's work include Acute Myocardial Infarction Research (8 papers), Coronary Interventions and Diagnostics (6 papers) and Cardiac Valve Diseases and Treatments (5 papers). Alan Whelan is often cited by papers focused on Acute Myocardial Infarction Research (8 papers), Coronary Interventions and Diagnostics (6 papers) and Cardiac Valve Diseases and Treatments (5 papers). Alan Whelan collaborates with scholars based in Australia, United Kingdom and New Zealand. Alan Whelan's co-authors include W. H. F. Sutherland, Sylvia A. de Jong, Michael Williams, M. P. McCormick, Stephen G. Worthley, Randall Hendriks, D. Walters, Ian T. Meredith, Robert Whitbourn and M. Worthley and has published in prestigious journals such as Journal of the American College of Cardiology, American Heart Journal and Metabolism.

In The Last Decade

Alan Whelan

19 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Whelan Australia 8 135 101 70 51 45 20 287
Paola Cheli Italy 6 141 1.0× 46 0.5× 36 0.5× 66 1.3× 21 0.5× 7 375
Mirosław Dłużniewski Poland 10 300 2.2× 49 0.5× 169 2.4× 27 0.5× 55 1.2× 54 594
Carlo Mannina United States 8 118 0.9× 44 0.4× 26 0.4× 11 0.2× 36 0.8× 24 333
Nicolas Barber‐Chamoux France 9 174 1.3× 124 1.2× 53 0.8× 12 0.2× 33 0.7× 19 352
David Chieng Australia 17 512 3.8× 125 1.2× 66 0.9× 63 1.2× 27 0.6× 67 807
Chi-Bom Chae South Korea 5 188 1.4× 34 0.3× 64 0.9× 31 0.6× 16 0.4× 8 397
P. Kaiser Switzerland 5 111 0.8× 43 0.4× 76 1.1× 17 0.3× 42 0.9× 6 262
Elisa Catasca Italy 10 125 0.9× 73 0.7× 94 1.3× 30 0.6× 7 0.2× 12 461
Dick A.C.M. Kruijssen Netherlands 9 169 1.3× 37 0.4× 91 1.3× 11 0.2× 42 0.9× 16 351
Valeria Ludovici Italy 7 117 0.9× 21 0.2× 36 0.5× 12 0.2× 91 2.0× 9 302

Countries citing papers authored by Alan Whelan

Since Specialization
Citations

This map shows the geographic impact of Alan Whelan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Whelan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Whelan more than expected).

Fields of papers citing papers by Alan Whelan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Whelan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Whelan. The network helps show where Alan Whelan may publish in the future.

Co-authorship network of co-authors of Alan Whelan

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Whelan. A scholar is included among the top collaborators of Alan Whelan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Whelan. Alan Whelan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eccleston, D., E. Chowdhury, T.A. Rafter, et al.. (2022). Long-Term Outcomes of Contemporary Percutaneous Coronary Intervention with the Xience Drug-Eluting Stent: Results from a Multicentre Australian Registry. Journal of Clinical Medicine. 12(1). 280–280. 1 indexed citations
2.
Worthley, Stephen G., Simon Redwood, David Hildick‐Smith, et al.. (2021). Transcatheter reshaping of the mitral annulus in patients with functional mitral regurgitation: one-year outcomes of the MAVERIC trial. EuroIntervention. 16(13). 1106–1113. 11 indexed citations
3.
Patterson, Tiffany, John Gregson, Andrejs Ērglis, et al.. (2021). Two‐year outcomes from the MitrAl ValvE Re paIr Clinical ( MAVERIC ) trial: a novel percutaneous treatment of functional mitral regurgitation. European Journal of Heart Failure. 23(10). 1775–1783. 9 indexed citations
4.
Loh, Poay Huan, Jens Flensted Lassen, Nigel Jepson, et al.. (2020). Asia Pacific consensus document on coronary bifurcation interventions. EuroIntervention. 16(9). e706–e714. 6 indexed citations
5.
Eccleston, D., D. Cehic, Ting‐Wei Lin, et al.. (2018). Cardiac Device Outcomes in Australia are not Influenced by Institutional Case Volume: Results from the Genesis National Multi-Centre Registry (GCOR). Heart Lung and Circulation. 27. S152–S153. 1 indexed citations
6.
Morgan, Holly, Michael McCann, Alan Whelan, & Richard Clugston. (2017). Right Coronary Dissection and Left Anterior Descending Thrombus: Dual Dilemma in a Young Cardiac Arrest Survivor. Journal of Emergency Medicine. 52(6). e233–e236.
7.
Worthley, Stephen G., Andrejs Ērglis, Simon Redwood, et al.. (2017). TCT-461 6 Month Outcomes of Transcatheter Annular Reduction Therapy (TART) with the ARTO™ System for Functional Mitral Regurgitation. Journal of the American College of Cardiology. 70(18). B190–B190. 2 indexed citations
8.
Judkins, Chris, et al.. (2017). Comparison of Safety and Efficacy of Unfractionated Heparin Versus Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention. Heart Lung and Circulation. 26(12). 1277–1281. 1 indexed citations
9.
Eccleston, D., M. Horrigan, T.A. Rafter, et al.. (2017). Improving Guideline Compliance in Australia With a National Percutaneous Coronary Intervention Outcomes Registry. Heart Lung and Circulation. 26(12). 1303–1309. 13 indexed citations
10.
Haq, Muhammad Asrar ul, Matthew Erickson, James M. Rankin, & Alan Whelan. (2016). Late Strut Fracture Within a Partially Resorbed Bioresorbable Vascular Scaffold: A Possible Cause of Late Scaffold Thrombosis and Acute Coronary Syndrome. Heart Lung and Circulation. 26(4). e26–e28. 2 indexed citations
11.
Worthley, Stephen G., Randall Hendriks, M. Worthley, et al.. (2015). Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I study. Cardiovascular revascularization medicine. 16(7). 413–417. 57 indexed citations
13.
Eccleston, D., et al.. (2013). Predictors of Readmission after Coronary Angioplasty in Australia. Results from a National Multi-Centre Registry. Heart Lung and Circulation. 22. S149–S149. 1 indexed citations
15.
Hendriks, Randall, et al.. (2008). Takotsubo cardiomyopathy complicated by Dressler's syndrome. The Medical Journal of Australia. 188(12). 725–727. 6 indexed citations
16.
Whelan, Alan, et al.. (2007). Increased Mortality among Patients Sustaining Hip Fractures Requiring Surgery in a District General Hospital. Hip International. 17(3). 160–163. 1 indexed citations
17.
Whelan, Alan, et al.. (2007). Increased mortality among patients sustaining hip fractures requiring surgery in a district general hospital. Hip International. 17(3). 160–163. 1 indexed citations
18.
Whelan, Alan, et al.. (2004). Effects of white and red wine on endothelial function in subjects with coronary artery disease. Internal Medicine Journal. 34(5). 224–228. 91 indexed citations
19.
20.
Blyth, Christopher C., et al.. (2002). Evaluation of clinical guidelines for the management of Staphylococcus aureus bacteraemia. Internal Medicine Journal. 32(5-6). 224–232. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026